Aptamers Market generated rapidly and applied in the specific detection, inhibition, and characteriz
- sagar joshi
- Nov 19, 2018
- 1 min read
Aptamers Market are oligonucleotides or peptide molecules that bind to a target lipid, nucleic acid molecules or proteins. They are generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. Aptamers are multipurpose and cost-effective which offer complementary or alternative solutions to the antibodies
Global Aptamers Market is expected to register a growth of significant CAGR 20.2% during the forecast period (2018–2023).
Growth in this market is credited to the improvements in aptamer development technologies, rising research and development investments for the development and manufacturing of recombinant products by major players and rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Increasing use of aptamers in drug discovery and disease treatment may influence this market positively over forecast period.
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/aptamers-market-6630
Some of the key players in the global aptamers market are Aptamer Sciences, Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Ophthotech Corporation, Am Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Neoventures Biotechnology Inc., Somalogic, Inc., Trilink Biotechnologies, Inc., Vivonics, Inc., Noxxon Pharma, and others.
Opmerkingen